An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.
An 8-Week, Multi-Centre,Randomised Double-Blind, Placebo Controlled, Parallel Group Study To Evaluate The Efficacy,Toleration And Safety Of (+)- [S,S]- Reboxetine In The Treatment Of Stress Urinary Incontinence (SUI) In Women.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
British Columbia
-
Surrey, British Columbia, Canada, V3V-1N1
- Pfizer Investigational Site
-
Victoria, British Columbia, Canada, V8T5G1
- Pfizer Investigational Site
-
-
Ontario
-
Kitchener, Ontario, Canada, N2M 5N4
- Pfizer Investigational Site
-
Oakville, Ontario, Canada, L6H 3P1
- Pfizer Investigational Site
-
-
Quebec
-
Montreal, Quebec, Canada, H3S 1Z1
- Pfizer Investigational Site
-
Pointe-Claire, Quebec, Canada, H9R 4S3
- Pfizer Investigational Site
-
-
-
-
Alaska
-
Anchorage, Alaska, United States, 99508
- Pfizer Investigational Site
-
-
Arizona
-
Sun City, Arizona, United States, 85351
- Pfizer Investigational Site
-
Tucson, Arizona, United States, 85712
- Pfizer Investigational Site
-
Tucson, Arizona, United States, 85712-5803
- Pfizer Investigational Site
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- Pfizer Investigational Site
-
-
California
-
Atherton, California, United States, 94027
- Pfizer Investigational Site
-
Carmichael, California, United States, 95608
- Pfizer Investigational Site
-
Laguna Woods, California, United States, 92653
- Pfizer Investigational Site
-
Murrieta, California, United States, 92562
- Pfizer Investigational Site
-
Newport Beach, California, United States, 92660
- Pfizer Investigational Site
-
Sacramento, California, United States, 95825
- Pfizer Investigational Site
-
San Diego, California, United States, 92103
- Pfizer Investigational Site
-
Tarzana, California, United States, 91356
- Pfizer Investigational Site
-
Temecula, California, United States, 92591
- Pfizer Investigational Site
-
Torrance, California, United States, 90505
- Pfizer Investigational Site
-
Vista, California, United States, 92084
- Pfizer Investigational Site
-
-
Colorado
-
Aurora, Colorado, United States, 80012
- Pfizer Investigational Site
-
Denver, Colorado, United States, 80220
- Pfizer Investigational Site
-
Denver, Colorado, United States, 80210
- Pfizer Investigational Site
-
Wheat Ridge, Colorado, United States, 80033
- Pfizer Investigational Site
-
-
Connecticut
-
New London, Connecticut, United States, 06320
- Pfizer Investigational Site
-
Waterbury, Connecticut, United States, 06708
- Pfizer Investigational Site
-
-
Florida
-
Aventura, Florida, United States, 33180
- Pfizer Investigational Site
-
New Port Richey, Florida, United States, 34652
- Pfizer Investigational Site
-
Panama City, Florida, United States, 32405
- Pfizer Investigational Site
-
Panama City, Florida, United States, 32407
- Pfizer Investigational Site
-
Pembroke Pines, Florida, United States, 33028
- Pfizer Investigational Site
-
Port Richey, Florida, United States, 34668
- Pfizer Investigational Site
-
West Palm Beach, Florida, United States, 33407
- Pfizer Investigational Site
-
-
Georgia
-
Alpharetta, Georgia, United States, 30005
- Pfizer Investigational Site
-
-
Idaho
-
Coeur D Alene, Idaho, United States, 83814
- Pfizer Investigational Site
-
-
Illinois
-
Arlington Heights, Illinois, United States, 60004
- Pfizer Investigational Site
-
Chicago, Illinois, United States, 60616
- Pfizer Investigational Site
-
Melrose Park, Illinois, United States, 60160
- Pfizer Investigational Site
-
-
Indiana
-
Greenwood, Indiana, United States, 46143
- Pfizer Investigational Site
-
Indianapolis, Indiana, United States, 46202
- Pfizer Investigational Site
-
-
Iowa
-
Des Moines, Iowa, United States, 50309
- Pfizer Investigational Site
-
-
Kentucky
-
Louisville, Kentucky, United States, 40291
- Pfizer Investigational Site
-
-
Louisiana
-
Shreveport, Louisiana, United States, 71106
- Pfizer Investigational Site
-
-
Maryland
-
Greenbelt, Maryland, United States, 20770
- Pfizer Investigational Site
-
-
Massachusetts
-
Watertown, Massachusetts, United States, 02472
- Pfizer Investigational Site
-
-
Mississippi
-
Jackson, Mississippi, United States, 39202
- Pfizer Investigational Site
-
Jackson, Mississippi, United States, 39216
- Pfizer Investigational Site
-
-
Missouri
-
Liberty, Missouri, United States, 64068
- Pfizer Investigational Site
-
North Kansas City, Missouri, United States, 64116
- Pfizer Investigational Site
-
-
Nebraska
-
Omaha, Nebraska, United States, 68114
- Pfizer Investigational Site
-
-
Nevada
-
Henderson, Nevada, United States, 89014
- Pfizer Investigational Site
-
-
New Jersey
-
Edison, New Jersey, United States, 08837
- Pfizer Investigational Site
-
West Orange, New Jersey, United States, 07052
- Pfizer Investigational Site
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87108
- Pfizer Investigational Site
-
-
New York
-
Albany, New York, United States, 12208
- Pfizer Investigational Site
-
Garden City, New York, United States, 11530
- Pfizer Investigational Site
-
Garden City, New York, United States, 11530-1630
- Pfizer Investigational Site
-
Mineola, New York, United States, 11501
- Pfizer Investigational Site
-
Poughkeepsie, New York, United States, 12601
- Pfizer Investigational Site
-
-
North Carolina
-
Burlington, North Carolina, United States, 27215
- Pfizer Investigational Site
-
Charlotte, North Carolina, United States, 28204
- Pfizer Investigational Site
-
Concord, North Carolina, United States, 28025
- Pfizer Investigational Site
-
Fayetteville, North Carolina, United States, 28304
- Pfizer Investigational Site
-
Winston-salem, North Carolina, United States, 27103
- Pfizer Investigational Site
-
-
Ohio
-
Cincinnati, Ohio, United States, 45212
- Pfizer Investigational Site
-
-
Oklahoma
-
Bethany, Oklahoma, United States, 73008
- Pfizer Investigational Site
-
-
Oregon
-
Eugene, Oregon, United States, 97401
- Pfizer Investigational Site
-
Eugene, Oregon, United States, 97401-2676
- Pfizer Investigational Site
-
Medford, Oregon, United States, 97504
- Pfizer Investigational Site
-
Portland, Oregon, United States, 97239
- Pfizer Investigational Site
-
-
Pennsylvania
-
Colmar, Pennsylvania, United States, 18915
- Pfizer Investigational Site
-
Lancaster, Pennsylvania, United States, 17604
- Pfizer Investigational Site
-
Philadelphia, Pennsylvania, United States, 19114
- Pfizer Investigational Site
-
Pittsburgh, Pennsylvania, United States, 15213
- Pfizer Investigational Site
-
Sellersville, Pennsylvania, United States, 18960
- Pfizer Investigational Site
-
Sewickley, Pennsylvania, United States, 15143
- Pfizer Investigational Site
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02904
- Pfizer Investigational Site
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Pfizer Investigational Site
-
Columbia, South Carolina, United States, 29201
- Pfizer Investigational Site
-
Greer, South Carolina, United States, 29651
- Pfizer Investigational Site
-
Myrtle Beach, South Carolina, United States, 29572
- Pfizer Investigational Site
-
-
Tennessee
-
Knoxville, Tennessee, United States, 37920-1522
- Pfizer Investigational Site
-
Knoxville, Tennessee, United States, 37920
- Pfizer Investigational Site
-
-
Texas
-
Corpus Christi, Texas, United States, 78414
- Pfizer Investigational Site
-
Corsicana, Texas, United States, 75110
- Pfizer Investigational Site
-
Houston, Texas, United States, 77024
- Pfizer Investigational Site
-
San Antonio, Texas, United States, 78229
- Pfizer Investigational Site
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- Pfizer Investigational Site
-
Sandy, Utah, United States, 84070
- Pfizer Investigational Site
-
Sandy, Utah, United States, 84094
- Pfizer Investigational Site
-
West Jordan, Utah, United States, 84088
- Pfizer Investigational Site
-
-
Virginia
-
Virginia Beach, Virginia, United States, 23454
- Pfizer Investigational Site
-
-
Washington
-
Seattle, Washington, United States, 98104
- Pfizer Investigational Site
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinically significant stress urinary incontinence
Exclusion Criteria:
- History or evidence of any relevant confounding urological or neurological disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
|---|
|
Proof of concept study to assess the efficacy, tolerability and safety of SS-RBX vs. placebo in the treatment of SUI.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
|---|
|
To evaluate whether an upward dose adjustment affects the tolerability of SS-RBX.
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- A6061023
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.